Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells

April 22, 2024

https://www.globenewswire.com/news-release/2024/04/22/2867122/0/en/Intratumoral-Injection-of-Phio-s-PH-762-significantly-inhibits-tumor-growth-in-murine-tumor-models-and-may-generate-memory-specific-T-cells.html

-Injection in murine tumors shows the compound is well tolerated

-Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinoma

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.